The report includes recommendations for providers, and the findings could impact rules around prescribing, utilization review, and service delivery.
The report includes recommendations for providers, and the findings could impact rules around prescribing, utilization review, and service delivery.
After public feedback is received at the February 19th meeting, the fee schedule is expected to take effect March 15, 2026.
After expanding access to care by allowing these providers to treat injured workers, billing guidelines for these providers are being developed.
Under the proposal, the BWC would cover purchases through their surplus fund if the need stems from an allowed injury or occupational disease.
Stakeholder input could determine if the audit focuses on either topical analgesics or utilization review compliance.
This workshop will cover rules around panel provider lists, delegating follow-up care to physician assistants, and other clerical matters.
Public comments will be accepted on proposed guideline updates until December 19, 2025.
The fee schedule has not been updated since 2009, resulting in low reimbursement rates, which has impacted access to care.
Proposed updates also allow for electronic filing and service of all WCAB case related documents in EAMS rather than requiring service by mail.
2025 relative values for physicians will be incorporated, while NCCI medical data was reviewed to compare state trends to national trends.
The DWC is accepting public comments on rules that expedite medical benefits and the dispute resolution process until November 24th.
The Medical Fee Guide Committee also discussed PPO practices, psychiatric IMEs, and more.
Findings from a gabapentin/pregabalin audit are expected in early 2026, the DWC addressed billing discrepancies, and more.
Stakeholders provided feedback on the DWC’s proposed rules.
Written comments will be accepted via email until November 10th.
